Evidence map›Paper›PMID 38832780›Full record

ArticlemBio2024

Spatial recovery of the murine gut microbiota after antibiotics perturbation.

M Taguer, J Xiao, R Crawford, H Shi, M P Cheng, M Citron, G D Hannigan, S H Kasper

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M TaguerDiscovery Immunology, MRL, Merck & Co., Inc., Cambridge, Massachusetts, USA.ORCID 0000-0003-4714-8400
J XiaoInfectious Diseases and Vaccine Research, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.
R CrawfordInformatics Technology, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.
H ShiKanvas Biosciences, Inc., Monmouth Junction, New Jersey, USA.
M P ChengKanvas Biosciences, Inc., Monmouth Junction, New Jersey, USA.
M CitronInfectious Diseases and Vaccine Research, MRL, Merck & Co., Inc., West Point, Pennsylvania, USA.
G D HanniganInformatics Technology, MRL, Merck & Co., Inc., Cambridge, Massachusetts, USA.
S H KasperDiscovery Immunology, MRL, Merck & Co., Inc., Cambridge, Massachusetts, USA.ORCID 0009-0006-7431-6915

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial communities are highly complex, with interaction networks dictating ecosystem function. Bacterial interactions are constrained by the spatial organization of these microbial communities, yet studying the spatial organization of microbial communities at the single-cell level has been technically challenging. Here, we use the recently developed high-phylogenetic-resolution microbiota mapping by fluorescence IMPORTANCE: Antibiotics have broad off-target effects on the gut microbiome. When the microbial community is unable to recover from antibiotics, it can lead to increased susceptibility to gastrointestinal infections and increased risk of immunological and metabolic diseases. In this study, we work to better understand how the gut microbiota recovers from antibiotics by employing a recent technology to image the entire bacterial community at once. Through this approach, we characterize the spatial changes in the gut microbiota after treatment with model antibiotics in both the cecum and colon of mice. We find antibiotic- and biogeographic-dependent spatial changes between bacterial species and that many of these spatial colocalizations do not recover to baseline levels even 35 days after antibiotic administration.

Indexed as

Anti-Bacterial AgentsBacteriaCecumColonGastrointestinal MicrobiomeIn Situ Hybridization, FluorescenceVancomycinAmpicillinAnimalsMiceMice, Inbred C57BLPhylogenyAmpicillinAnti-Bacterial AgentsVancomycinantibioticsfluorescent in situ hybridizationmultiplexed imagingspatial microbiome

Identifiers

PMID38832780
PMCPMC11253616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.